mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.06 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.06 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.07 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.07 |